novel
coronaviru
cov
associ
sever
respiratori
diseas
middl
east
respiratori
syndrom
merscov
previous
known
human
coronaviruserasmu
medic
center
hcovemc
emerg
arabian
peninsula
date
human
case
merscov
report
fatal
anim
model
merscov
infect
human
need
elucid
mer
pathogenesi
develop
vaccin
antivir
studi
develop
rhesu
macaqu
model
merscov
use
intratrach
inocul
infect
monkey
show
clinic
sign
diseas
viru
replic
histolog
lesion
neutral
antibodi
product
indic
monkey
model
suitabl
studi
merscov
infect
coronavirus
cov
infect
human
wide
varieti
anim
caus
respiratori
enter
hepat
neurolog
diseas
vari
clinic
sever
base
genotyp
serolog
characterist
classifi
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
coronavirus
well
known
high
frequenc
recombin
high
mutat
rate
may
allow
adapt
new
host
ecolog
nich
best
exemplifi
sever
acut
respiratori
syndrom
sar
epidem
caus
sarscov
sarscov
shown
origin
anim
horsesho
bat
rhinolophu
sinicu
natur
reservoir
palm
civet
paguma
larvata
intermedi
host
allow
animaltohuman
transmiss
sinc
sar
epidem
mani
novel
cov
discov
human
anim
novel
betacoronaviru
lineag
c
includ
tylonycteri
bat
cov
tybatcov
pipistrellu
bat
cov
pibatcov
discov
lesser
bamboo
bat
pachypu
japanes
pipistrel
p
abramu
hong
kong
china
virus
found
close
relat
novel
strain
human
cov
refer
middl
east
respiratori
syndrom
cov
merscov
identifi
saudi
arabia
novel
human
viru
classifi
lineag
c
betacoronaviru
differ
cov
previous
found
human
includ
sar
date
human
case
merscov
report
fatal
merscov
associ
sever
respiratorytract
infect
renal
failur
fatal
similar
sarscov
merscov
close
relat
bat
cov
suggest
bat
may
natur
reservoir
famili
virus
specif
viru
egyptian
tomb
bat
show
nucleotid
ident
viru
human
index
casepati
current
unclear
whether
human
case
result
direct
zoonot
transmiss
bat
human
whether
intermedi
host
involv
howev
recent
studi
show
merscov
reactiv
antibodi
retir
race
camel
oman
neighbor
saudi
arabia
middl
eastern
nation
larg
amount
camel
meat
consum
everi
year
much
import
african
countri
like
egypt
epidemiolog
evid
may
suggest
batcamelhuman
viral
linkag
investig
need
defin
sourc
merscov
current
evid
effici
transmiss
human
merscov
howev
occurr
cluster
case
suggest
humantohuman
transmiss
possibl
rais
concern
regard
potenti
viru
caus
pandem
similar
caus
sarscov
pathogen
mechan
merscov
clear
neither
effect
vaccin
therapeut
drug
avail
prevent
treatment
develop
anim
model
merscov
infect
human
utmost
import
studi
pathogenesi
viru
test
efficaci
potenti
therapeut
prophylact
intervent
strategi
present
report
anim
model
merscov
infect
thu
limit
studi
nonhuman
primat
play
essenti
role
understand
variou
form
pathogen
could
reflect
variabl
clinic
symptom
patholog
human
previou
studi
report
nonhuman
primat
diseas
model
influenza
sar
virus
therefor
present
studi
explor
suitabl
rhesu
monkey
anim
model
merscov
isol
human
coronaviruserasmu
medic
center
hcovemc
infect
diseas
research
merscov
viru
discuss
among
staff
member
depart
pathogen
biolog
institut
laboratori
anim
scienc
ila
chines
academi
medic
scienc
peke
union
medic
colleg
pumc
merscov
anim
model
experi
protocol
discuss
explicitli
extens
among
staff
member
depart
pathogen
biolog
discuss
follow
addit
discuss
biosafeti
offic
facil
manag
ila
pumc
well
numer
specialist
sarscov
gener
infecti
diseas
field
throughout
china
research
procedur
approv
ila
institut
anim
care
use
committe
laboratori
safeti
committe
lsc
committe
recommend
number
anim
reduc
compli
reduct
replac
refin
principl
therefor
design
experi
includ
anim
test
anim
model
merscov
monkey
infect
viru
uninfect
monkey
control
approv
registr
number
experi
conduct
within
anim
biosafeti
level
facil
construct
accredit
base
nation
standard
ila
pumc
beij
china
merscov
strain
hcovemc
kind
gift
professor
fouchier
seed
stock
hcovemc
propag
vero
cell
seed
stock
dilut
design
titer
use
determin
hcovemc
tissu
cultur
infect
dose
tcid
perform
neutral
antibodi
assay
vero
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fetal
bovin
serum
fb
intern
unit
iu
ml
penicillin
streptomycin
cultur
co
four
monkey
age
year
inocul
intratrach
hcovemc
tcid
ml
dilut
dmem
monkey
anesthet
ml
inoculum
administ
intratrach
mockinfect
monkey
monkey
intratrach
inocul
dmem
includ
control
monkey
observ
twice
daili
detail
record
clinic
sign
symptom
morbid
mortal
includ
natur
onset
sever
durat
gross
visibl
chang
chest
xray
perform
inocul
day
postinocul
dpi
merscov
two
infect
monkey
control
monkey
sacrif
dpi
tissu
specimen
includ
lung
trachea
heart
spleen
kidney
brain
liver
colon
tissu
collect
variou
patholog
virolog
immunolog
test
virolog
immunolog
test
swab
sampl
oropharyng
nasal
turbin
cloacal
region
collect
dpi
blood
collect
dpi
total
rna
isol
individu
sampl
use
rneasi
mini
kit
qiagen
accord
manufactur
instruct
revers
transcript
rt
reaction
perform
use
superscript
iii
first
strand
synthesi
kit
invitrogen
accord
manufactur
instruct
complementari
dna
cdna
sampl
store
use
polymeras
chain
reaction
pcr
experiment
sampl
posit
control
hcovemc
duplic
cdna
sampl
obtain
total
rna
sampl
primer
use
hcovemc
describ
previous
specif
rnadepend
rna
polymeras
rdrp
gene
sequenc
primer
use
pcr
detect
follow
rdrpseqfwd
tgctat
wagtgctaagaatagrgc
r
ag
w
rdrpseqrev
gcatwgcncwgtcacacttagg
w
n
actg
amplif
protocol
follow
minut
follow
cycl
second
second
second
termin
elong
step
minut
case
amplif
product
obtain
pcr
assay
secondround
reaction
set
contain
reaction
mixtur
first
round
primer
rdrpseqfwd
use
first
round
rdrpseqrnest
cacttaggrtartcccawccca
thermal
cycl
perform
follow
minut
follow
cycl
second
second
second
follow
extens
step
tissu
sampl
homogen
final
weight
per
volum
suspens
dmem
clarifi
lowspe
centrifug
g
minut
swab
sampl
immers
ml
dmem
vortex
clarifi
lowspe
centrifug
g
minut
viru
titer
determin
vero
cell
monolay
grown
plate
vero
cell
seed
well
plate
incub
overnight
co
incub
serial
dilut
suspens
ad
well
quadrupl
viru
allow
adsorb
cell
hour
adsorpt
viral
inocula
remov
ml
medium
dmem
fb
ad
well
plate
incub
co
incub
day
cytopath
effect
cpe
observ
microscop
magnif
viru
titer
specimen
express
tcid
calcul
reedmuench
method
neutral
test
serum
sampl
dilut
initi
dilut
final
dilut
mix
tcid
ml
viru
incub
hour
step
perform
quadrupl
thereaft
virusserum
mixtur
ad
vero
cell
previous
seed
well
inocul
plate
incub
co
incub
day
cpe
viru
observ
microscop
magnif
anim
necropsi
perform
accord
standard
protocol
sampl
histolog
examin
store
neutralbuff
formalin
embed
paraffin
section
stain
hematoxylin
eosin
prior
examin
light
microscopi
altern
section
immunohistochem
stain
use
polyclon
antibodi
nucleoprotein
hcovemc
monkey
observ
daili
clinic
sign
diseas
dpi
bodi
weight
temperatur
record
rectal
temperatur
obtain
daili
first
week
challeng
temperatur
measur
specif
time
point
graph
temperatur
profil
figur
depict
mean
temperatur
mockinfect
merscovinfect
monkey
temperatur
infect
monkey
increas
dpi
return
normal
thereaft
moreov
within
first
day
infect
monkey
drastic
decreas
water
intak
none
infect
monkey
show
overt
weight
loss
compar
mockinfect
monkey
radiograph
imag
reveal
vari
degre
local
infiltr
interstiti
mark
figur
none
infect
monkey
die
experi
total
rna
isol
tissu
homogen
oropharyng
nasal
turbin
cloacal
swab
sampl
analyz
use
primer
specif
hcovemc
rdrp
gene
viral
rna
detect
lung
homogen
obtain
infect
monkey
dpi
howev
organ
remain
rtpcr
neg
tabl
viral
rna
detect
swab
sampl
tabl
nasal
turbin
oropharyng
cloacal
swab
collect
inocul
anim
pi
viru
titer
determin
endpoint
titrat
vero
cell
oropharyng
nasal
turbin
cloacal
swab
contain
detect
viru
titer
experi
agreement
rtpcr
result
sampl
tissu
describ
homogen
viru
titer
determin
anim
inocul
merscov
viru
could
detect
lung
tcid
ml
howev
sampl
kidney
trachea
brain
heart
liver
spleen
intestin
detect
viru
titer
level
hcovemcneutr
antibodi
evalu
neutral
antibodi
detect
mockinfect
monkey
contrast
infect
monkey
neutral
antibodi
detect
begin
dpi
reach
peak
titer
dpi
decreas
slightli
dpi
figur
two
merscovinfect
anim
euthan
dpi
trachea
lung
brain
heart
liver
spleen
kidney
intestin
histolog
virolog
examin
lung
lesion
present
inocul
monkey
grossli
congest
palpabl
nodul
show
scatter
distribut
particularli
evid
posterior
region
lobe
figur
microscop
lung
tissu
show
multifoc
mildtomoder
interstiti
pneumonia
exud
patholog
chang
figur
immunohistochemistri
also
perform
assess
presenc
merscovinfect
cell
tissu
collect
infect
anim
control
anim
figur
monkey
inocul
merscov
infect
cell
identifi
lung
region
area
patholog
chang
type
ii
pneumocyt
alveolar
macrophag
found
contain
viral
antigen
vascular
endothelium
observ
figur
addit
infect
cell
observ
organ
control
group
posit
area
identifi
organ
current
human
infect
merscov
report
develop
sever
acut
respiratori
ill
symptom
fever
cough
short
breath
often
renal
failur
half
report
patient
die
laboratoryconfirm
case
reportedli
experi
mild
respiratori
ill
develop
anim
model
reflect
variat
human
popul
challeng
studi
sought
develop
anim
model
display
symptom
studi
test
mous
ferret
guinea
pig
model
found
anim
suscept
merscov
unpublish
data
nonhuman
primat
use
evalu
vaccin
studi
diseas
pathogenesi
sever
respiratori
virus
includ
influenza
sarscov
respiratori
syncyti
viru
human
parainfluenza
virus
studi
rhesu
monkey
explor
model
merscov
monkey
model
support
viral
growth
also
manifest
respiratori
gener
ill
along
tissu
patholog
merscov
dose
use
studi
tcid
intratrach
infect
infect
observ
temperatur
increas
infect
anim
fever
one
marker
merscov
infect
human
includ
monkey
temperatur
increas
signific
dpi
bodi
weight
monkey
also
record
prior
viral
infect
signific
chang
mean
weight
observ
viru
replic
detect
lung
infect
anim
howev
detect
viru
rna
measur
titer
nasal
turbin
oropharyng
sampl
suggest
monkey
shed
viru
upperrespiratori
tract
human
merscov
detect
lowerrespiratorytract
specimen
high
viral
load
wherea
nasopharyng
sampl
weakli
posit
inconclus
monkey
model
show
similar
result
primari
merscov
infectionrel
patholog
human
acut
pneumonia
accompani
multiorgan
dysfunct
acut
renal
failur
compat
broad
rang
tissu
tropism
cell
cultur
suscept
test
patholog
present
pneumonia
also
observ
infect
monkey
figur
howev
extrapulmonari
lesion
found
find
consist
report
vincent
et
al
report
similar
find
acut
localizedtowidespread
pneumonia
result
mildtomoder
clinic
diseas
human
renal
failur
major
symptom
mer
howev
observ
patholog
chang
kidney
reason
discrep
clear
deserv
studi
possibl
dissemin
viru
may
yet
occur
viru
limit
lung
detect
viru
blood
determin
whether
anim
infect
develop
neutral
antibodi
assay
merscov
evid
seroconvers
inocul
anim
merscovspecif
antibodi
detect
monkey
serum
sampl
begin
dpi
titer
increas
gradual
neutral
antibodi
protect
assay
show
infect
monkey
produc
neutral
antibodi
could
prevent
infect
due
rechalleng
merscov
result
also
indic
potent
immunogen
merscov
suggest
possibl
use
viru
inactiv
attenu
vaccin
summari
viral
detect
assay
immunolog
respons
patholog
chang
lung
infect
anim
suggest
merscov
abl
establish
infect
inocul
monkey
addit
rhesu
macaqu
appear
suitabl
model
studi
merscov
pathogenesi
potenti
prophylact
therapeut
intervent
strategi
stage
pathogenesi
merscov
human
still
clear
rhesu
macaqu
infect
merscov
laboratori
recogn
necessari
search
suitabl
anim
model
similar
diseas
present
observ
among
laboratoryconfirm
human
case
howev
anoth
anim
model
defin
rhesu
macaqu
may
use
infect
model
evalu
vaccin
antivir
drug
state
recent
paper
